Literature DB >> 29526013

Correction to: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.

Alireza Nazari1,2, Hossein Khorramdelazad2, Gholamhossein Hassanshahi3,4.   

Abstract

Following the publication from the original article, it came to our attention that we unintentionally neglected to acknowledge some text overlap with previous publications.

Entities:  

Year:  2018        PMID： 29526013     DOI： 10.1007/s10147-018-1257-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  4 in total

Review 1.  CXCR4 signaling in health and disease.

Authors:  Tommaso Pozzobon; Giacomo Goldoni; Antonella Viola; Barbara Molon
Journal:  Immunol Lett       Date:  2016-06-27       Impact factor: 3.685

Review 2.  CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

Authors:  Dan G Duda; Sergey V Kozin; Nathaniel D Kirkpatrick; Lei Xu; Dai Fukumura; Rakesh K Jain
Journal:  Clin Cancer Res       Date:  2011-02-24       Impact factor: 12.531

Review 3.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Authors:  Xueqing Sun; Guangcun Cheng; Mingang Hao; Jianghua Zheng; Xiaoming Zhou; Jian Zhang; Russell S Taichman; Kenneth J Pienta; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 4.  Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.

Authors:  Alireza Nazari; Hossein Khorramdelazad; Gholamhossein Hassanshahi
Journal:  Int J Clin Oncol       Date:  2017-10-11       Impact factor: 3.402
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.